Zachary Roberts, EVP of R&D: Allogene Therapeutics ALLO Sell · Filed 01/23

Trade details

Type: Insider sale
Amount: $40,979.64
Shares · price: 26,269 sh · $1.56 a share
Held after: 616,866 sh
Stock: Allogene Therapeutics ALLO
Person: Zachary RobertsEVP of R&D
Trade date: 26/01/21
Filed: 26/01/23
Days to filing: 2 days

Sold 4.1% of holdings

Share of holding sold: 4.1%

Allogene Therapeutics trades, last 26 weeks

What else happened in Allogene Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/22~02/20

Zachary Roberts's recent trades

Zachary RobertsEVP of R&D
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$63.2K
35,700 sh
$63.2K
Filed 02/04
Traded 02/02
Zachary RobertsEVP of R&D
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$63.4K
35,700 sh
$63.4K
Filed 02/02
Traded 02/02
Zachary RobertsEVP of R&D
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$40.9K
26,269 sh
$40.9K
Filed 01/21
Traded 01/21
Zachary RobertsEVP of R&D
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$32K
18,832 sh
$32K
Filed 25/02/05
Traded 25/02/03
Zachary RobertsOfficer
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$32K
18,832 sh
$32K
Filed 25/02/03
Traded 25/02/03